)
Visual
test
Genetic Analysis
Genetic Analysis (GEAN) investor relations material
Genetic Analysis Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary27 Feb, 2026
Executive summary
Achieved record sales in Q4 2025, driven by recurring revenues from GA-map® kit sales and first US sales of the GA-map® MHI GutHealth test.
Expanded commercial activities in the US and Europe, with new customer onboardings and partnerships supporting growth.
Completed development phase of IBD Precision Dx biomarker panel, entering final validation.
Financial highlights
Q4 2025 sales revenue: NOK 6.4 million, up 2.9% year-over-year (9.8% at constant currency).
Full year 2025 sales revenue: NOK 16.7 million, up 5.2% (9.6% at constant currency).
EBITDA for Q4 2025: NOK -1.6 million (vs. NOK 0.4 million in Q4 2024); full year EBITDA: NOK -6.1 million (vs. NOK -9.0 million in 2024).
Net loss Q4 2025: NOK -2.6 million (vs. NOK -0.9 million); full year net loss: NOK -11.4 million (improved from NOK -14.8 million).
Cash and cash equivalents at year-end: NOK 24.0 million (vs. NOK 13.4 million), positively impacted by a major customer pre-payment.
Outlook and guidance
Positive momentum in the global microbiome market expected to continue, with strong growth prospects.
Ongoing collaborations and new customer acquisitions underline robust demand for microbiome testing.
Focus remains on delivering standardized, scalable testing solutions and expanding product portfolio.
Strategy to mitigate US import duty impact
Sustainability of cash flow excluding pre-payments
Commercial timeline for IBD Precision Dx test
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Genetic Analysis
- Q3 2025 sales rose 2.9% year-over-year, with new product launches and US expansion driving growth.GEAN
Q3 202527 Nov 2025 - Q2 2025 delivered strong sales growth, positive EBITDA, and strategic expansion in key markets.GEANQ2 202527 Aug 2025
- Core kit sales up 32% YTD; cost cuts and new products drive improved margins and outlook.GEANQ3 202413 Jun 2025
- Reagent kit sales soared 135% in Q2 2024, fueling growth and supporting US expansion.GEANQ2 202413 Jun 2025
- Sales down, margins up, China entry and capital raise position GA for future growth.GEANQ1 20256 Jun 2025
- Record sales, first positive EBITDA, and a key pharma partnership drive future growth.GEANQ4 20245 Jun 2025
Next Genetic Analysis earnings date
Q1 202629 May, 2026
Genetic Analysis
Next Genetic Analysis earnings date
Q1 202629 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage